◼ Archived
Business
Beyond statins, one drug lowered heart attack risk by 20%
Amgen's Repatha demonstrates a lower risk of heart attacks compared to ezetimibe in a large real-world study.
2 trends tracked about this subject — the full history, oldest to newest below.
Amgen's Repatha demonstrates a lower risk of heart attacks compared to ezetimibe in a large real-world study.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.